BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34614265)

  • 21. Contrast-enhanced CT radiomics features to preoperatively identify differences between tumor and proximal tumor-adjacent and tumor-distant tissues of resectable esophageal squamous cell carcinoma.
    Gao D; Tan BG; Chen XQ; Zhou C; Ou J; Guo WW; Zhou HY; Li R; Zhang XM; Chen TW
    Cancer Imaging; 2024 Jan; 24(1):11. PubMed ID: 38243339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvage treatment for lymph node recurrence after radical resection of esophageal squamous cell carcinoma.
    Chen J; Yin W; Yao H; Gu W
    Radiat Oncol; 2019 Sep; 14(1):169. PubMed ID: 31533757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of lymphadenectomy for lymph node recurrence after esophagectomy or definitive chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Watanabe M; Mine S; Yamada K; Shigaki H; Baba Y; Yoshida N; Kajiyama K; Yamamoto N; Sano T; Baba H
    Gen Thorac Cardiovasc Surg; 2014 Nov; 62(11):685-92. PubMed ID: 24965711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-treatment CT radiomics to predict 3-year overall survival following chemoradiotherapy of esophageal cancer.
    Larue RTHM; Klaassen R; Jochems A; Leijenaar RTH; Hulshof MCCM; van Berge Henegouwen MI; Schreurs WMJ; Sosef MN; van Elmpt W; van Laarhoven HWM; Lambin P
    Acta Oncol; 2018 Nov; 57(11):1475-1481. PubMed ID: 30067421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiomics Nomogram with Added Nodal Features Improves Treatment Response Prediction in Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Study.
    Li K; Zhang S; Hu Y; Cai A; Ao Y; Gong J; Liang M; Yang S; Chen X; Li M; Tian J; Shan H
    Ann Surg Oncol; 2023 Dec; 30(13):8231-8243. PubMed ID: 37755566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of the radiomics-based model in progression-free survival of hypopharyngeal cancer treated with chemoradiation.
    Mo X; Wu X; Dong D; Guo B; Liang C; Luo X; Zhang B; Zhang L; Dong Y; Lian Z; Liu J; Pei S; Huang W; Ouyang F; Tian J; Zhang S
    Eur Radiol; 2020 Feb; 30(2):833-843. PubMed ID: 31673835
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
    Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.
    Ikawa T; Ishihara R; Konishi K; Morimoto M; Hirata T; Kanayama N; Yamamoto S; Matsuura N; Wada K; Hayashi K; Ogawa K; Teshima T
    Cancer Med; 2019 Aug; 8(10):4547-4554. PubMed ID: 31222974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
    Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
    Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy.
    Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C
    Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining the radiomic features and traditional parameters of
    Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
    Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can peritumoral radiomics increase the efficiency of the prediction for lymph node metastasis in clinical stage T1 lung adenocarcinoma on CT?
    Wang X; Zhao X; Li Q; Xia W; Peng Z; Zhang R; Li Q; Jian J; Wang W; Tang Y; Liu S; Gao X
    Eur Radiol; 2019 Nov; 29(11):6049-6058. PubMed ID: 30887209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of Locoregional Recurrence-Free Survival of Oesophageal Squamous Cell Carcinoma After Chemoradiotherapy Based on an Enhanced CT-Based Radiomics Model.
    Kong J; Zhu S; Shi G; Liu Z; Zhang J; Ren J
    Front Oncol; 2021; 11():739933. PubMed ID: 34631575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma.
    Wang Y; Xiao P; Yang N; Wang X; Ma K; Wu L; Zhang W; Zhuang X; Xie T; Fang Q; Lan M; Wang Q; Peng L
    World J Surg Oncol; 2021 Oct; 19(1):303. PubMed ID: 34657600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
    Gong J; Zhang W; Huang W; Liao Y; Yin Y; Shi M; Qin W; Zhao L
    Radiother Oncol; 2022 Sep; 174():8-15. PubMed ID: 35750106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SUV
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    World J Surg Oncol; 2021 Apr; 19(1):105. PubMed ID: 33836789
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 38. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
    Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
    Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-region radiomics signature: Integrating primary tumor and lymph node computed tomography features improves survival prediction in esophageal squamous cell cancer.
    Lu N; Zhang WJ; Dong L; Chen JY; Zhu YL; Zhang SH; Fu JH; Yin SH; Li ZC; Xie CM
    Comput Methods Programs Biomed; 2021 Sep; 208():106287. PubMed ID: 34311416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.